Galderma Research & Development SNC discovers, develops, and markets therapeutic, corrective, and aesthetic solutions. The company is headquartered in Biot, France.

Behringwerke AG, a subsidiary of Sanofi, is a German company located in Marburg. The firm produces specialty chemicals and pharmaceutical products.

KOSÉ specializes mainly in the manufacturing and marketing of cosmetics. Its strength lies in its unique and high-value exclusive cosmetics. It aims to offer original and valuable products in all of its brand categories, particularly in the high-prestige and prestige brands, which are characterized by high added value, as well as the cosmetaries* brands, which offer inexpensive and affordable products, mainly in the self-service category. It also offers through various sales channels highly original brands with a wide variety of features to precisely meet the diverse needs of customers. Its brands are divided into two major categories: the KOSÉ brand, a brand that has the company’s name on it, and the individual brands, which represent a wide variety of highly original brands. It was founded in 1946 and is located in Nihonbashi, Tokyo, Japan.

Lisen Imprinting Diagnostic Technology (Wuxi) Co., Ltd., established on 2016-10-21, Business scope includes probes,Kit experimental material development;Diagnostic Technology R&D;Technology development in the field of biotechnology,technical consulting,Technical Services and Technology Transfer;Development of diagnostic reagents;biological reagent,Sales of Class I Medical Devices;Production of Class I Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Lithuanian University of Health Sciences (Lithuanian: Lietuvos sveikatos mokslų universitetas, LSMU) is a medical school in Kaunas, Lithuania. The present-day Lithuanian University of Health Sciences is a consolidation of two institutions of higher education, Kaunas University of Medicine and the Lithuanian Veterinary Academy. It uses the Hospital of Lithuanian University of Health Sciences Kaunas Clinics and the Kaunas Red Cross Hospital as a teaching hospitals.

Digna Biotech is a holding company which provides biomedical dsicovery, research, development, and clinical testing services to clients in the pharmaceutical sector. Its pipeline consists of products for the treatment of sclerodermia, keratosis, multiple sclerosis, corneal ulcers, porphyria, and acute liver failure. The company was founded on February 23, 2003 and is headquartered in Pamplona, Spain.

Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders. Angiogenesis, i.e. the formation of new blood vessels, is a characteristic feature of many severe pathologies such as cancer, rheumatoid arthritis, and age-related macular degeneration. The company has been a pioneer in the isolation, engineering and clinical development of lead products capable of targeting angiogenesis in-vivo and has been the first in the world to demonstrate that human monoclonal antibodies, specific for a marker of angiogenesis, can efficiently and selectively target the tumor neo-vasculature both in animal models and in cancer patients. At present, Philogen has four promising anti-cancer antibody derivatives and an antibody derivative for the treatment of rheumatoid arthritis in clinical studies. Two registrational studies are in planning. Our Zurich-based daughter company Philochem serving as the R&D unit isolates the most promising candidate products, while in Siena (Italy) the pharmaceuticals are produced according to GMP standards and advanced to clinical trials. Philogen generates revenue from a diversified range of activities, has signed agreements with major pharmaceutical companies and owns a diversified portfolio of international patents.

Founded in 2013, Zhiyi Bio focuses on the research and development of second-generation probiotics and Live Biotherapeutics. Based on the discovery of strains and drug development with independent intellectual property rights, a lot of innovative research has been carried out, and the “Know-How” from strains to drugs has been established, and the innovative live bacteria drug SK08 is about to enter the clinic. On this basis, Zhiyi will continue to strengthen the research and development of the relationship between human microbiome and disease, including microbial culture group and pathobionts research, target determination and separation of new functional strains.

ISDIN SA engages in the manufacture and development of skin care products. It offers moisturizers, anti-aging, sun protection, ampules and serums, eye treatments, foundation, cleansers, body care, hair thinning products, and brittle nails. The company was founded in 1975 and is headquartered in Barcelona, Spain.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

SOINN Inc. develops various devices and information systems utilizing patent technology. The company was founded by Osamu Hasegawa in July 2014 and is headquartered in Kodaira, Japan.

Life Science Institute strengthens and expands the healthcare business of the Mitsubishi Chemical Holdings (MCHC) Group. The company believes that the realization of a "society that continues to be healthy" is the solution that everyone can understand and the desired form of society. The LSII Group provides new value through comprehensive healthcare solutions to realize a "society that remains healthy" as a partner for patients suffering from various illnesses and all those who desire health.

Golden Biotechnology Corp. is a biopharmaceutical company which produces drugs and herbal supplement. It mainly focuses on discovery and clinical development of innovative therapeutic new drugs (NCE) and products that prevent and treat diseases. The company specialized in anti-cancer and anti-atherosclerosis drugs. It drugs preparation and applications in oncology, cardio-metabolic syndromes, autoimmune diseases, neurodegenerative diseases and infectious diseases. Golden Biotechnology was founded by Sheng Yung Liu and Li Yu Wu on September 27, 2002 and is headquartered in New Taipei, Taiwan.

Manufactures pharmaceuticals and diagnostic substances

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Arizona Board of Regents oversees college activities. The company was founded in 1864 and is headquartered in Phoenix, AZ.

Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company. The company was founded in 1982 and headquartered in Morris Plains, New Jersey.